Nevro Corp.

Nevro Corp.verified

NVRO

Price:

$3.81

Market Cap:

$142.77M

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.[Read more]

Industry

Medical - Devices

IPO Date

2014-11-06

Stock Exchange

NYSE

Ticker

NVRO

The ROE as of December 2024 (TTM) for Nevro Corp. (NVRO) is -24.76%

According to Nevro Corp.’s latest financial reports and current stock price. The company's current ROE is -24.76%. This represents a change of 297.30% compared to the average of -6.23% of the last 4 quarters.

Nevro Corp. (NVRO) Historical ROE (quarterly & annually)

How has NVRO ROE performed in the past?

The mean historical ROE of Nevro Corp. over the last ten years is -23.72%. The current -24.76% ROE has changed 4.40% with respect to the historical average. Over the past ten years (40 quarters), NVRO's ROE was at its highest in in the September 2022 quarter at 25.08%. The ROE was at its lowest in in the March 2019 quarter at -20.59%.

Quarterly (TTM)
Annual

Average

-23.72%

Median

-20.71%

Minimum

-47.92%

Maximum

0.93%

Nevro Corp. (NVRO) ROE by Quarter and Year

Discovering the peaks and valleys of Nevro Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 139.10%

Maximum Annual ROE = 0.93%

Minimum Annual Increase = -3494.86%

Minimum Annual ROE = -47.92%

Quarterly (TTM)
Annual
YearROEChange
2023-31.46%-3494.86%
20220.93%-102.14%
2021-43.27%102.33%
2020-21.38%-55.38%
2019-47.92%139.10%
2018-20.04%36.24%
2017-14.71%15.29%
2016-12.76%-55.61%
2015-28.74%61.21%
2014-17.83%-53.77%

Nevro Corp. (NVRO) Average ROE

How has NVRO ROE performed in the past?

The current ROE of Nevro Corp. (NVRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-24.60%

5-year avg

-28.62%

10-year avg

-23.72%

Nevro Corp. (NVRO) ROE vs. Peers

How is NVRO’s ROE compared to its peers?

Nevro Corp.’s ROE is less than NuVasive, Inc. (4.86%), less than Integer Holdings Corporation (7.30%), greater than Glaukos Corporation (-26.64%), less than CONMED Corporation (15.04%), greater than Pulmonx Corporation (-53.88%), less than IRadimed Corporation (23.98%), greater than Orthofix Medical Inc. (-21.25%), greater than NeuroPace, Inc. (-205.41%), greater than OrthoPediatrics Corp. (-7.64%), greater than Sight Sciences, Inc. (-47.28%), greater than CVRx, Inc. (-89.06%), greater than RxSight, Inc. (-14.00%), greater than Paragon 28, Inc. (-38.77%), less than ProSomnus, Inc. (50.75%), less than LivaNova PLC (1.88%), less than Electromed, Inc. (15.32%), greater than Surmodics, Inc. (-9.56%),

Build a custom stock screener for Nevro Corp. (NVRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nevro Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nevro Corp. (NVRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nevro Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Nevro Corp.'s ROE?

How is the ROE calculated for Nevro Corp. (NVRO)?

What is the highest ROE for Nevro Corp. (NVRO)?

What is the 3-year average ROE for Nevro Corp. (NVRO)?

What is the 5-year average ROE for Nevro Corp. (NVRO)?

How does the current ROE for Nevro Corp. (NVRO) compare to its historical average?